UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | R | S | T | V | W
Number of items: 137.

A

Aballéa, S; Chancellor, JV; Raikou, M; Drummond, MF; Weinstein, MC; Jourdan, S; Bridgewater, J; (2007) Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US. Cancer , 109 (6) 1082 - 1089. 10.1002/cncr.22512.

Al-Alwan, MM; Okkenhaug, K; Vanhaesebroeck, B; Hayflick, JS; Marshall, AJ; (2007) Requirement for phosphoinositide 3-kinase p110delta signaling in B cell antigen receptor-mediated antigen presentation. J Immunol , 178 (4) 2328 - 2335.

Allen, OR; Gott, AL; Hartley, JA; Hartley, JM; Knox, RJ; McGowan, PC; (2007) Functionalised cyclopentadienyl titanium compounds as potential anticancer drugs. DALTON T (43) 5082 - 5090. 10.1039/b708283p.

Alonzi, R; Padhani, AR; Taylor, NJ; Stirling, JJ; Saunders, MI; Hoskin, PJ; (2007) Physiological changes within the prostate caused by androgen withdrawal. In: CLINICAL ONCOLOGY. (pp. S6 - S6).

Arkenau, HT; Chong, G; Cunningham, D; Watkins, D; Agarwal, R; Sirohi, B; ... Horwich, A; + view all (2007) The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma. Ann Oncol , 18 (3) 541 - 545. 10.1093/annonc/mdl434.

Arkenau, HT; Chong, G; Cunningham, D; Watkins, D; Sirohi, B; Chau, I; ... Matutes, E; + view all (2007) Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience. Haematologica , 92 (2) 271 - 272.

Arkenau, HT; Chua, YJ; Cunningham, D; (2007) Current treatment strategies in elderly patients with metastatic colorectal cancer. Clin Colorectal Cancer , 6 (7) 508 - 515.

Arkenau, HT; Gordon, C; Cunningham, D; Norman, A; Wotherspoon, A; Chau, I; (2007) Mucosa associated lymphoid tissue lymphoma of the lung: the Royal Marsden Hospital experience. Leuk Lymphoma , 48 (3) 547 - 550. 10.1080/10428190601094388.

Arkenau, HT; Gordon, C; Murphy, F; Cunningham, D; (2007) Paraneoplastic syndrome: subacute cerebellar degeneration in Hodgkin's disease. Leuk Lymphoma , 48 (4) 819 - 822. 10.1080/10428190601164249.

Ayaru, L; Pereira, SP; Alisa, A; Pathan, AA; Williams, R; Davidson, B; ... Behboudi, S; + view all (2007) Unmasking of alpha-fetoprotein-specific CD4(+) T cell responses in hepatocellular carcinoma patients undergoing embolization. J IMMUNOL , 178 (3) 1914 - 1922.

B

Bajwa, A; Blunt, N; Vyas, S; McKenzie, G; Bridgewater, J; Hochhauser, D; Obichere, A; (2007) Predictive factors of outcome in patients with asymptomatic stage IV colorectal cancer and irresectable liver metastases. In: Annals of Oncology. (pp. V1170 - V1170).

Begent, RHJ; Sharma, SK; Mayer, A; Tolner, B; Pedley, RB; Wilkins, D; ... Chester, KA; + view all (2007) Incorporating single chain Fv antibodies into therapeutic proteins: issues exemplified in antibody-directed enzyme prodrug therapy (ADEPT). In: IMMUNOLOGY. (pp. 42 - 42). BLACKWELL PUBLISHING

Beresford, M; Lyburn, I; Sanghera, B; Makris, A; Wong, WL; (2007) Serial integrated F-18-fluorodeoxythymidine PET/CT monitoring neoadjuvant chemotherapeutic response in invasive ductal carcinoma. BLACKWELL PUBLISHING

Beresford, MJ; Ravichandran, D; Makris, A; (2007) Neoadjuvant endocrine therapy in breast cancer. Cancer Treatment Reviews , 33 (1) 48 - 57.

Brown, T; Taherbhai, Z; Sexton, J; Sutterfield, A; Turlington, M; Jones, J; ... Hartley, JA; + view all (2007) Synthesis and biophysical evaluation of minor-groove binding C-terminus modified pyrrole and imidazole triamide analogs of distamycin. BIOORGAN MED CHEM , 15 (1) 474 - 483. 10.1016/j.bmc.2006.09.037.

Buchler, T; Bomanji, J; Lee, SM; (2007) FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity. Haematologica , 92 (11) e120 - e121. 10.3324/haematol.11856. Gold open access

Burdak-Rothkamm, S; Short, S; Folkard, M; Rothkamm, K; Prise, KM; (2007) ATR-Dependent Radiation Induced g-H2AX Foci In Bystander Primary Human Astrocytes And Glioma Cells. Oncogene , 26 (7) 993 - 1002. 10.1038/sj.onc.1209863.

C

Chong, IY; Hoskin, PJ; (2007) Vaginal vault brachytherapy for low risk endometrial carcinoma. In: CLINICAL ONCOLOGY. (pp. S8 - S8).

Chong, IY; Rojas, A; Hoskin, PJ; (2007) Does a fall in lymphocyte or neutrophil count during chemoradiotherapy predict survival in cervical carcinoma? In: CLINICAL ONCOLOGY. (pp. S25 - S26).

Clingen, PH; Arlett, CF; Hartley, JA; Parris, CN; (2007) Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links. EXP CELL RES , 313 (4) 753 - 760. 10.1016/j.yexcr.2006.11.007.

Cutillas, PR; Vanhaesebroeck, B; (2007) Quantitative profile of five murine core proteomes using label-free functional proteomics. Mol Cell Proteomics , 6 (9) 1560 - 1573. 10.1074/mcp.M700037-MCP200.

D

Dancey, G; Violet, J; Othman, S; Parker, S; Green, A; Sharma, S; ... McNamara, C; + view all (2007) Phase I trial of the I-131-labelled Anti-CD25 antibody basiliximab in the treatment of patients with relapsed or refractory lymphoma. In: BLOOD. (pp. 199A - 200A). AMER SOC HEMATOLOGY

de Bruin, EC; van de Pas, S; van de Velde, CJ; van Krieken, JH; Peltenburg, LT; Marijnen, CA; Medema, JP; (2007) Gene expression profiling reveals two separate mechanisms regulating apoptosis in rectal carcinomas in vivo. Apoptosis , 12 (9) 1671 - 1680. 10.1007/s10495-007-0088-2.

de Heer, P; de Bruin, EC; Klein-Kranenbarg, E; Aalbers, RI; Marijnen, CA; Putter, H; ... Dutch Colorectal Cancer Group,; + view all (2007) Caspase-3 activity predicts local recurrence in rectal cancer. Clin Cancer Res , 13 (19) 5810 - 5815. 10.1158/1078-0432.CCR-07-0343.

de Heer, P; Gosens, MJ; de Bruin, EC; Dekker-Ensink, NG; Putter, H; Marijnen, CA; ... Dutch Colorectal Cancer Group,; + view all (2007) Cyclooxygenase 2 expression in rectal cancer is of prognostic significance in patients receiving preoperative radiotherapy. Clin Cancer Res , 13 (10) 2955 - 2960. 10.1158/1078-0432.CCR-06-2042.

Dearling, JL; Pedley, RB; (2007) Technological advances in radioimmunotherapy. Clin Oncol (R Coll Radiol) , 19 (6) 457 - 469. 10.1016/j.clon.2007.03.016.

Dearling, JLJ; Pedley, RB; (2007) Technological advances in Radioimmunotherapy. CLIN ONCOL-UK , 19 (6) 457 - 469. 10.1016/j.cion.2007.03.016.

Dearling, JLJ; Qureshi, U; Begent, RHJ; Pedley, RB; (2007) Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-D-glucose results in reduction of therapeutic efficacy. CLIN CANCER RES , 13 (6) 1903 - 1910. 10.1158/1078-0432.CCR-06-2094.

Dearling, JLJAPRB; (2007) Antibody directed radionuclide therapy. In: Hoskin, PJ, (ed.) Radiotherapy in Practice: Volume III Radioisotopes. (9 - 45). Oxford University Press.

Diez, P; Hoskin, PJ; (2007) Conventional and CT-based volumes in IFRT for supradiaphragmatic malignant lymphoma. In: CLINICAL ONCOLOGY. (pp. S16 - S16).

E

Eickholt, BJ; Ahmed, AI; Davies, M; Papakonstanti, EA; Pearce, W; Starkey, ML; ... Vanhaesebroeck, B; + view all (2007) Control of Axonal Growth and Regeneration of Sensory Neurons by the p110 delta PI 3-Kinase. PLOS ONE , 2 (9) , Article e869. 10.1371/journal.pone.0000869. Green and gold open access
file

El Emir, E; Qureshi, U; Dearling, JLJ; Boxer, GM; Clatworthy, I; Folarin, AA; ... Pedley, RB; + view all (2007) Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomas. CANCER RES , 67 (24) 11896 - 11905. 10.1158/0008-5472.CAN-07-2967.

El-Emir, E; Dearling, JLJ; Huhalov, A; Robson, MP; Boxer, G; Neri, D; ... Pedley, RB; + view all (2007) Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models. BRIT J CANCER , 96 (12) 1862 - 1870. 10.1038/sj.bjc.6603806. Gold open access

El-Emir, E; Qureshi, U; Dearling, JLJ; Boxer, GM; Clatworthy, I; Folarin, AA; ... Pedley, RB; + view all (2007) Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomas. Cancer Research , 67 2639 - 2646.

Ellis, T; Evans, DA; Martin, CRH; Hartley, JA; (2007) A 96-well DNase I footprinting screen for drug-DNA interactions. NUCLEIC ACIDS RES , 35 (12) , Article e89. 10.1093/nar/gkm467. Gold open access

F

Forster, M; Kaye, S; Oza, A; Sklenar, I; Johri, A; Cheung, W; ... Gore, M; + view all (2007) A phase Ib and pharmacokinetic trial of patupilone combined with carboplatin in patients with advanced cancer. Clin Cancer Res , 13 (14) 4178 - 4184. 10.1158/1078-0432.CCR-06-1653.

Forster, MD; Ormerod, MG; Agarwal, R; Kaye, SB; Jackman, AL; (2007) Flow cytometric method for determining folate receptor expression on ovarian carcinoma cells. Cytometry A , 71 (11) 945 - 950. 10.1002/cyto.a.20456.

Fox, J; Glasspool, D; Grecu, D; Modgil, S; South, M; Patkar, V; (2007) Argumentation-based inference and decision making - A medical perspective. IEEE INTELL SYST , 22 (6) 34 - 41.

Funes, JM; Quintero, M; Henderson, S; Martinez, D; Qureshi, U; Westwood, C; ... Boshoff, C; + view all (2007) Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production. P NATL ACAD SCI USA , 104 (15) 6223 - 6228. 10.1073/pnas.0700690104. Gold open access

Furnari, FB; Fenton, T; Bachoo, RM; Mukasa, A; Stommel, JM; Stegh, A; ... Cavenee, WK; + view all (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes & Development , 21 (21) 2683 - 2710. 10.1101/gad.1596707.

G

Geering, B; Cutillas, PR; Nock, G; Gharbi, SI; Vanhaesebroeck, B; (2007) Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers. Proc Natl Acad Sci U S A , 104 (19) 7809 - 7814. 10.1073/pnas.0700373104.

Geering, B; Cutillas, PR; Vanhaesebroeck, B; (2007) Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits? In: Biochem Soc Trans. (pp. 199 - 203).

H

Hochhauser, D; Kotecha, M; O'Hare, C; Morris, PJ; Hartley, JM; Taherbhai, Z; ... Hartley, JA; + view all (2007) Modulation of topoisomerase II alpha expression by a DNA sequence-specific polyamide. MOL CANCER THER , 6 (1) 346 - 354. 10.1158/1535-7163.MCT-06-0503.

Hochhauser, D; Kotecha, M; O'Hare, C; Morris, PJ; Hartley, JM; Taherbhai, Z; ... Hartley, JA; + view all (2007) Modulation of topoisomerase II expression in mammalian cells with a sequence-specific polyamide. Molecular Cancer Therapeutics , 6 (1) 346 - 354.

Hoskin, PJ; Bownes, P; Bryant, L; Ostler, P; (2007) HDR monotherapy brachytherapy for localised prostate cancer. In: CLINICAL ONCOLOGY. (pp. S7 - S7).

Hoskin, PJ; Carnell, DM; Taylor, NJ; Smith, RE; Stirling, JJ; Daley, FM; ... Padhani, AP; + view all (2007) Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY , 68 (4) 1065 - 1071.

Hoskin, PJ; Chin, Y; Wong, W; Rojas, A; (2007) The value of SUV in FDG PET for lymphoma. In: CLINICAL ONCOLOGY. (pp. S32 - S32).

Hoskin, PJ; Dearnaley, DP; (2007) Hypofractionation in clinical trials for prostate cancer. ELSEVIER SCIENCE LONDON

Hoskin, PJ; Motohashi, K; Bownes, P; Bryant, L; Ostler, P; (2007) High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial. Radiotherapy & Oncology , 84 (2) 114 - 120.

Hoskin, PJ; Venselaar, J; (2007) Prostate brachytherapy in Europe: Growth, practice and guidelines. UNSPECIFIED

Howie, AJ; (2007) The association among C4d staining in renal transplant biopsies, the production of donor-specific HLA antibodies, and graft outcome. Transplantation , 83 (4) 373 - 374. 10.1097/01.tp.0000251424.65487.5c.

Huddart, RA; O'Doherty, MJ; Padhani, A; Rustin, GJ; Mead, GM; Joffe, JK; ... Stenning, SPNCRITTCSG; + view all (2007) 18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group. Clinical Oncology , 25 (11) 1310 - 1315.

J

Jain, P; Cerone, MA; Leblanc, AC; Autexier, C; (2007) Telomerase and neuronal marker status of differentiated NT2 and SK-N-SH human neuronal cells and primary human neurons. J Neurosci Res , 85 (1) 83 - 89. 10.1002/jnr.21094.

Ji, H; Rintelen, F; Waltzinger, C; Bertschy Meier, D; Bilancio, A; Pearce, W; ... Rommel, C; + view all (2007) Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation. Blood , 110 (8) 2940 - 2947. 10.1182/blood-2007-04-086751.

Ji, H; Rintelen, F; Waltzinger, C; BertschyMeier, D; Pearce, W; Hirsch, E; ... Rommel, C; + view all (2007) Inactivation of PI3Kg and PI3Kd distorts T cell development and renders susceptibility to multiple organ inflammation. INFLAMMATION RESEARCH , 56 S444 - S444.

Joerger, M; Huitema, ADR; Richel, DJ; Dittrich, C; Pavlidis, N; Briasoulis, E; ... Schellens, JHM; + view all (2007) Population PKPD of paclitaxel and carboplatin in ovarian cancer patients: A study by the EORTC-PAMM-NDDG. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , 63 (4) 505 - 505.

Joerger, M; Huitema, ADR; Richel, DJ; Dittrich, C; Pavlidis, N; Briasoulis, E; ... Schellens, JHM; + view all (2007) Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: A study by the European Organization for Research and Treatment of Cancer-Pharmacology and Molecular Mechanisms Group and New Drug Development Group. CLIN CANCER RES , 13 (21) 6410 - 6418. 10.1158/1078-0432.CCR-07-0064.

Judith, D; (2007) CT scan plan to combat cancer. Sunday Herald

K

Kandola, S; Anyamene, N; Payne, H; Harland, S; (2007) Transdermal oestrogen therapy as a second-line hormonal intervention in prostate cancer: a bad experience. BJU International , 99 (1) 53 - 55.

Kiakos, K; Sato, A; Asao, T; McHugh, PJ; Lee, M; Hartley, JA; (2007) DNA sequence-selective adenine alkylation, mechanism of adduct repair, and in vivo antitumor activity of the novel achiral seco-amino-cyclopropylbenz[e]indolone analogue of duocarmycin AS-I-145. MOL CANCER THER , 6 (10) 2708 - 2718. 10.1158/1535-7163.MCT-07-0294.

Kishimoto, H; Ohteki, T; Yajima, N; Kawahara, K; Natsui, M; Kawarasaki, S; ... Suzuki, A; + view all (2007) The Pten/PI3K pathway governs the homeostasis of Valpha14iNKT cells. Blood , 109 (8) 3316 - 3324. 10.1182/blood-2006-07-038059.

Kogelberg, H; Sharma, SK; Qureshi, U; Tolner, B; Lowdell, M; Shabakhti, H; ... Chester, KA; + view all (2007) Clearance mechanism of a mannoseylated antibody enzyme fusion protein used in experimental cancer therapy. In: (Proceedings) NCRI Cancer Conference proceedings. (pp. 65 - ?).

Kogelberg, H; Tolner, B; Sharma, SK; Lowdell, MW; Qureshi, U; Robson, M; Hillyer, T; (2007) Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy (vol 17, pg 36, 2007). GLYCOBIOLOGY , 17 (10) 1030 - 1030. 10.1093/glycob/cw1053.

Kogelberg, H; Tolner, B; Sharma, SK; Lowdell, MW; Qureshi, U; Robson, M; ... Chester, KA; + view all (2007) Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy. GLYCOBIOLOGY , 17 (1) 36 - 45. 10.1093/glycob/cwl053.

Kogelberg, H; Tolner, B; Thomas, G; Di Cara, D; Ramesh, B; Sodha, S; ... Chester, K; + view all (2007) Generation of a single-chain Fv with binding specificity for the integrin, alpha v beta 6, by rational structure based antibody engineering – a promising agent for cancer therapy. In: (Proceedings) NCRI Cancer Conference Proceedings.

Koukourakis, MI; Bentzen, SM; Giatromanolaki, A; Wilson, GD; Daley, FM; Saunders, MI; ... Harris, AL; + view all (2007) Endogenous markers of two separate hypoxia response pathways (HIF2 alpha and CA9) predict radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. Journal of Clinical Oncology , 24 (5) 727 - 735. 10.1200/jco.2005.02.7474.

Kulkarni, AA; Loddo, M; Leo, E; Rashid, M; Eward, KL; Fanshawe, TR; ... Stoeber, K; + view all (2007) DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma. CLIN CANCER RES , 13 (20) 6153 - 6161. 10.1158/1078-0432.CCR-07-0671.

L

Ladenstein, R; Whelan, J; Oberlin, O; Weston, C; Jurgens, H; (2007) Multivariate analysis based risk grouping of Ewing tumours (ET) with extra-pulmonary metastatic disease (EPMD): Final results from the Euro Ewing 99 study. In: ASCO Chicago 2007.

Lai, P; Bomanji, JB; Mahmood, S; Nagabhushan, N; Syed, R; Gacinovic, S; ... Ell, PJ; + view all (2007) Detection of tumour thrombus by 18F-FDG-PET/CT imaging. Eur J Cancer Prev , 16 (1) 90 - 94. 10.1097/01.cej.0000220641.46470.77.

Lankester, KJ; Maxwell, RJ; Pedley, RB; Dearling, JL; Qureshi, UA; El-Emir, E; ... Tozer, GM; + view all (2007) Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, I-131-A5B7, even at doses that are sub-optimal for vascular shut-down. INT J ONCOL , 30 (2) 453 - 460.

Latz, J; Adachi, S; Symanowski, J; Nakagawa, K; Tamura, T; Hanna, N; ... Calvert, H; + view all (2007) Correlation of pemetrexed (PEM) NSCLC exposure-response relationships (ERRS) to clinical study results from western and Japanese patient populations. J THORAC ONCOL , 2 (8) S455 - S456.

Ledermann, JA; Gabra, H; Jayson, GC; Spanswick, VJ; Rustin, GJ; Jitlal, M; ... Hartley, JA; + view all (2007) Combination chemotherapy with carboplatin and gemcitabine in patients in platinum-resistant ovarian cancer chemotherapy: a phase II study demonstrating inhibition of DNA cross-link repair by gemcitabine. In: EJC SUPPLEMENTS. (pp. 320 - 320). PERGAMON-ELSEVIER SCIENCE LTD

Lee, SM; Woll, PJ; James, LJ; Hatton, M; Ali, K; Spiro, SG; ... Hackshaw, A; + view all (2007) A phase III randomised, double blind, placebo controlled trial of etoposide/carboplatin with or without thalidomide in advanced small cell lung cancer (SCLC). In: (Proceedings) Presidential Symposium. 12th World Conference on Lung Cancer, Seoul, Korea.. (pp. S306 - S307). Journal of Thoracic Oncology

Lee, SM; Woll, PJ; Rudd,; RM,; Gower, NH; Ottensmeier, CH; ... Hackshaw, A; + view all (2007) A phase III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced non-small cell lung cancer (NSCLC). In: (Proceedings) Proffered Paper. 12th World Conference on Lung Cancer, Seoul, Korea.. (pp. S359 - ?). Journal of Thoracic Oncology

Lewis, IJ; Nooij, MA; Whelan, J; Sydes, MR; Grimer, R; Hogendoorn, PCW; ... Taminiau, AHM; + view all (2007) Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup. Journal of the National Cancer Institute , 99 (2) 112 - 128.

Lewis, IJ; Nooij, MA; Whelan, J; Sydes, MR; Grimer, R; Hogendoorn, PCW; ... European Osteosarcoma Intergrp,; + view all (2007) Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup. J NATL CANCER I , 99 (2) 112 - 128. 10.1093/inci/djk015.

Lowe, H; Tolner, B; Kogelberg, H; Begent, R; Robson, L; Taylorson, C; Chester, K; (2007) A novel human enzyme with a bis-chloro-phenol prodrug for Antibody Directed Enzyme Prodrug Therapy (ADEPT). In: (Proceedings) NCRI Cancer Conference Proceedings.

Lucy, M; (2007) Why I didn’t have any qualms about taking thalidomide. The Express 56 - ?.

M

Mandeville, HC; Ng, Q; Milner, J; Taylor, NJ; Stirling, JJ; Padhani, AR; ... Hoskin, PJ; + view all (2007) CA4P and external beam radiotherapy in prostate cancer with assessment of effect by DCE-MRI. In: CLINICAL ONCOLOGY. (pp. S38 - S38).

Marelli, L; Stigliano, R; Triantos, C; Senzolo, M; Cholongitas, E; Davies, N; ... Burroughs, AK; + view all (2007) Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol , 30 (1) 6 - 25. 10.1007/s00270-006-0062-3.

Marina, N; S Bielack, MS; M Bernstein, TB-B; S Smeland, AH; Whelan, J; (2007) International collaboration is feasible in trials for rare conditions: the EURAMOS experience. In: ASCO Chicago. (pp. Abstract 2 - ?).

Marsh, D; Vigor, K; Kogelberg, H; Tolner, B; Meyer, T; Begent, R; ... Chester, K; + view all (2007) Antibody targeted magnetic nanoparticles for cancer imaging and therapy. In: (Proceedings) NCRI Cancer Conference Proceedings.

McCloskey, EV; Beneton, M; Charlesworth, D; Kayan, K; deTakats, D; Dey, A; ... Kanis, JA; + view all (2007) Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. J Bone Miner Res , 22 (1) 135 - 141. 10.1359/jbmr.061008.

N

Nashed, BF; Zhang, T; Al-Alwan, M; Srinivasan, G; Halayko, AJ; Okkenhaug, K; ... Marshall, AJ; + view all (2007) Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation. Eur J Immunol , 37 (2) 416 - 424. 10.1002/eji.200636401.

Nehls, O; Okech, T; Hsieh, CJ; Enzinger, T; Sarbia, M; Borchard, F; ... Klump, B; + view all (2007) Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX. Br J Cancer , 96 (9) 1409 - 1418. 10.1038/sj.bjc.6603728.

Ng, F; Mastoroudes, H; Paul, E; Davies, N; Tibballs, J; Hochhauser, D; ... Meyer, T; + view all (2007) A comparison of hickman line- and port-a-cath-associated complications in patients with solid tumours undergoing chemotherapy. CLIN ONCOL-UK , 19 (7) 551 - 556. 10.1016/j.clon.2007.04.003.

Ng, Q-S; Goh, V; Milner, J; Stratford, MR; Folkes, LK; Tozer, GM; ... Hoskin, PJ; + view all (2007) Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study. The Lancet Oncology , 8 (2) 111 - 118. 10.1016/S1470-2045(07)70001-3.

Ng, QS; Goh, V; Carnell, D; Meer, K; Padhani, AR; Saunders, MI; Hoskin, PJ; (2007) Tumor antivascular effects of radiotherapy combined with combretastatin A4 phosphate in human non-small-cell lung cancer. International Journal of Radiation Oncology Biology Physics , 67 (5) 1375 - 1380.

Ng, QS; Goh, V; Milner, J; Padhani, AR; Saunders, MI; Hoskin, PJ; (2007) Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography. International Journal of Radiation Oncology Biology Physics , 67 (2) 417 - 424.

O

O'Hare, CC; Uthe, P; Mackay, H; Blackmon, K; Jones, J; Brown, T; ... Hartley, JA; + view all (2007) Sequence recognition in the minor groove of DNA by covalently linked formamido imidazole-pyrrole-imidazole polyamides: Effect of H-pin linkage and linker length on selectivity and affinity. BIOCHEMISTRY-US , 46 (42) 11661 - 11670. 10.1021/bi701053a.

Okkenhaug, K; Ali, K; Vanhaesebroeck, B; (2007) Antigen receptor signalling: a distinctive role for the p110 delta isoform of Pl3K. TRENDS IN IMMUNOLOGY , 28 (2) 80 - 87. 10.1016/j.it.12.007.

Okkenhaug, K; Ali, K; Vanhaesebroeck, B; (2007) Antigen receptor signalling: a distinctive role for the p110delta isoform of PI3K. Trends in Immunology , 28 (2) 80 - 87. 10.1016/j.it.2006.12.007. Green and gold open access
file

P

Papakonstanti, EA; Ridley, AJ; Vanhaesebroeck, B; (2007) The p110delta isoform of PI 3-kinase negatively controls RhoA and PTEN. EMBO J , 26 (13) 3050 - 3061. 10.1038/sj.emboj.7601763.

Penn, H; Howie, AJ; Kingdon, EJ; Bunn, CC; Stratton, RJ; Black, CM; ... Denton, CP; + view all (2007) Scleroderma renal crisis-patient characteristics and outcomes in 110 cases from a single centre. In: RHEUMATOLOGY. (pp. I4 - I5). OXFORD UNIV PRESS

Penn, H; Howie, AJ; Kingdon, EJ; Bunn, CC; Stratton, RJ; Black, CM; ... Denton, CP; + view all (2007) Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM-INT J MED , 100 (8) 485 - 494. 10.1093/qjmed/hcm052.

Pepper, C; Lowe, H; Fegan, C; Thurieau, C; Thurston, DE; Hartley, JA; Delavault, P; (2007) Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells. BRIT J CANCER , 97 (2) 253 - 259. 10.1038/sj.bjc.6603853.

Plummer, ER; Calvert, H; (2007) Targeting poly(ADP-ribose) polymerase: A two-armed strategy for cancer therapy. CLIN CANCER RES , 13 (21) 6252 - 6256. 10.1158/1078-0432.CCR-07-0617.

Plummer, R; Attard, G; Pacey, S; Li, L; Razak, A; Perrett, R; ... De Bono, J; + view all (2007) Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancers. CLIN CANCER RES , 13 (20) 6187 - 6194. 10.1158/1078-0432.CCR-07-0950.

Plummer, R; Vida, L; Perrett, R; Spicer, J; Stopfer, P; Shahidi, M; ... de Bono, J; + view all (2007) A phase I and pharmacokinetic (PK) study of BIBW 2992, an oral irreversible dual EGFR/HER2 inhibitor. In: EJC SUPPLEMENTS. (pp. 108 - 108). PERGAMON-ELSEVIER SCIENCE LTD

Porschen, R; Arkenau, H-T; Kubicka, S; Greil, R; Seufferlein, T; Freier, W; ... Schmoll, H-J; + view all (2007) In reply [10]. Journal of Clinical Oncology , 25 (31) 5045 - 5046. 10.1200/JCO.2007.13.4841.

Porschen, R; Arkenau, H-T; Kubicka, S; Greil, R; Seufferlein, T; Freier, W; ... Schmoll, H-J; + view all (2007) In reply [8]. Journal of Clinical Oncology , 25 (31) 5042 - 5043. 10.1200/JCO.2007.14.4386.

Porschen, R; Arkenau, HT; Kubicka, S; Greil, R; Seufferlein, T; Freier, W; ... AIO Colorectal Study Group,; + view all (2007) Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group. J Clin Oncol , 25 (27) 4217 - 4223. 10.1200/JCO.2006.09.2684.

R

Rachid, Z; Brahimi, F; Qiu, Q; Williams, C; Hartley, JM; Hartley, JA; Jean-Claude, BJ; (2007) Novel nitrogen mustard-armed combi-molecules for the selective targeting of epidermal growth factor receptor overexperessing solid tumors: Discovery of an unusual structure-activity relationship. J MED CHEM , 50 (11) 2605 - 2608. 10.1021/jm070144p.

Rades, D; Veninga, T; Stalpers, LJ; Basic, H; Hoskin, PJ; Karstens, JH; ... Dunst, J; + view all (2007) Improved posttreatment functional outcome is associated with better survival in patients irradiated for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys , 67 (5) 1506 - 1509. 10.1016/j.ijrobp.2006.11.029.

Ravn, P; Patel, A; Bicknell, R; Begent, RHJ; Pedley,; R, B; ... Meyer, T; + view all (2007) UNSPECIFIED In: (Proceedings) NCRI Cancer Conference Proceedings. (pp. 59 - ?).

Roylance, R; Seddon, B; McTiernan, A; Sykes, K; Daniels, S; Whelan, J; (2007) Experience of the use of trabectedin (ET-743, Yondelis (TM)) in 21 patients with pre-treated advanced sarcoma from a single centre. CLIN ONCOL-UK , 19 (8) 572 - 576. 10.1016/j.cton.2007.05.006.

Roylance, R; Seddon, BM; Sykes, K; Beresford, A; Daniels, S; Whelan, J; (2007) Experience of the use of trabectedin (ET-743, Yondelis) in twenty one patients with pre-treated advanced sarcoma from a single centre. Clinical Oncology , 19 (8) 572 - 576. 10.1016/j.clon.2007.05.006.

Rustin, GJ; Mead, GM; Stenning, SP; Vasey, PA; Aass, N; Huddart, RA; ... Kirk, SJ; + view all (2007) Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197 - The National Cancer Research Institute Testis Cancer Clinical Studies Group. JOURNAL OF CLINICAL ONCOLOGY , 25 (11) 1310 - 1315. 10.1200/JCO.2006.08.4889.

S

Sainz-Pastor, N; Tolner, B; Robson, L; Parizek, P; Binz, K; Forrer, P; ... Chester, K; + view all (2007) Selection and evaluation of designed ankyrin repeat proteins (DARPins) reactive with carcinoembryonic antigen (CEA). In: (Proceedings) NCRI Cancer Conference Proceedings.

Sexton, J; Mackay, H; Brown, T; Kotecha, M; O'Hare, C; Kluza, J; ... Lee, M; + view all (2007) MEDI 309-Regulation of the topoisomerase II alpha gene using polyamides that binds to the inverted CCAAT box present in the promoter. ABSTR PAP AM CHEM S , 234 ? - ?.

Short, SC; Buffa, FM; Bourne, S; Koritzinsky, M; Wouters, BG; Bentzen, SM; (2007) Dose- and time-dependent changes in gene expression in human glioma cells after low radiation doses. RADIATION RESEARCH , 168 (2) 199 - 208. 10.1667/RR0940.1.

Short, SC; Martindale, C; Bourne, S; Brand, J; Johnston, P; (2007) DNA damage response in gliomas and normal human astrocytes. Neuro-Oncology , 9 (4) 404 - 411.

Short, SC; Martindale, C; Bourne, SM; Brand, G; Woodcock, M; Johnston, P; (2007) Damage signalling after TMZ and radiation in glioma cells and sensitisation by inhibition of repair in G2. In:

Sielaff, A; Cooper, A; Mackay, H; Brown, T; O'Hare, C; Kluza, J; ... Lee, M; + view all (2007) Binding of f-PIP and JH-37 to the inverted CCAAT box-2 of the topoisomerase II promoter. ABSTR PAP AM CHEM S , 233 613 - 613.

Sikic, BI; Wakelee, HA; Von Mehren, M; Lewis, NL; Plummer, ER; Calvert, AH; ... Burris, HA; + view all (2007) A phase 1b study to assess the safety of lexatumumab, a human monoclonal antibody that activates TRAIL-R2, in combination with gemcitabine, pemetrexed, doxorubicin or FOLFIRI. MOL CANCER THER , 6 (12) 3454S - 3455S.

Sky, NRSM; (2007) Thalidomide could get cancer treatment licence. UNSPECIFIED

Smith, AE; Pinkney, M; Piggott, NH; Calvert, H; Milton, ID; Lunec, J; (2007) Novel monoclonal antibody for detection of folate receptor alpha in paraffin-embedded tissues. HYBRIDOMA , 26 (5) 281 - 288. 10.1089/hyb.2007.0512.

Spicer, J; Calvert, H; Vidal, L; Azribi, F; Perrett, R; Shahidi, M; ... Plummer, R; + view all (2007) Activity of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, in non-small cell lung cancer (NSCLC) with mutated EGFR. J THORAC ONCOL , 2 (8) S410 - S410.

Strauss, SJ; Higginbottom, K; Jüliger, S; Maharaj, L; Allen, P; Schenkein, D; ... Joel, SP; + view all (2007) The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines. Cancer Res , 67 (6) 2783 - 2790. 10.1158/0008-5472.CAN-06-3254.

Swanton, C; Marani, M; Pardo, O; Warne, PH; Kelly, G; Sahai, E; ... Nicke, B; + view all (2007) Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell , 11 (6) 498 - 512. 10.1016/j.ccr.2007.04.011.

T

Tolner, B; Smith, L; Hillyer, T; Bhatia, J; Beckett, P; Robson, L; ... Chester, KA; + view all (2007) From laboratory to Phase I/II cancer trials with recombinant biotherapeutics. EUR J CANCER , 43 (17) 2515 - 2522. 10.1016/j.ejca.2007.08.027.

Toumpanakis, C; Meyer, T; Caplin, ME; (2007) Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab , 21 (1) 131 - 144. 10.1016/j.beem.2007.01.005.

Toumpanakis, C; Quigley, A; Srirajaskanthan, R; Karpathakis, A; Krepska, A; Davidson, A; ... Caplin, ME; + view all (2007) The new radiolabelled somatostatin analogue 90Yttrium-dota-octreotate for the treatment of metastatic neuroendocrine tumors: Initial results and tolerability in a series of 47 patients. In: GUT. (pp. A42 - A43). B M J PUBLISHING GROUP

V

Vassileva, V; Grant, J; De Souza, R; Allen, C; Piquette-Miller, M; (2007) Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model. CANCER CHEMOTH PHARM , 60 (6) 907 - 914. 10.1007/s00280-007-0449-0.

W

Westbury, CB; Pearson, A; Nerurkar, A; Reis-Filho, JS; Steele, D; Peckitt, C; ... Yarnold, JR; + view all (2007) Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride. BRIT J RADIOL , 80 (959) 934 - 938. 10.1259/bjr/25046649.

Whelan, J; Dolbear, C; Mak, V; Moller, H; Davies, E; (2007) Where do teenagers and young adults receive treatment for cancer? J PUBLIC HEALTH-UK , 29 (2) 178 - 182. 10.1093/pubmed/fdm006.

Whelan, J; Smeland, S; Marina, N; Bernstein, M; Sydes, MR; Butterfass-Bahoul, T; ... Bielack, S; + view all (2007) Successful pan-European and trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma: EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECTEUROCORES). In: ). European Journal of Cancer Supplements 5:408-409, 2007. (Abstract).

Whelan, J; Smeland, S; Marina, N; Bernstein, M; Sydes, MR; May, B; ... Bielack, S; + view all (2007) Successful pan-European and trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma: EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECT-EUROCORES). In: EJC SUPPLEMENTS. (pp. 408 - 409). PERGAMON-ELSEVIER SCIENCE LTD

Whelan, J; Smeland S, MN; Bernstein M, SM; May E, B-BT; Perisoglou M, CD; Calaminus G, MR; ... Bielack, S; + view all (2007) Successful trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma: EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECT-EUROCORES) – a potential model for collaboration in rare diseases. In: National Cancer Research Institute Cancer Conference, Birmingham.

Whelan, J; Sydes, M; Bielack, S; Smeland, S; Marina, N; May, E; ... Bernstein, M; + view all (2007) Successful trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma: EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECT-EUROCORES) – a potential model for collaboration in rare diseases. In: British Sarcoma Group meeting 2008 conference abstracts http://www.bsgconference.org.uk/abst2008/absp-sydes.pdf:.

Whelan, JLI; Nooij M, SM; Grimer R, HP; Memon M, WS; Uscinska B, VGM; Kirkpatrick A, HE; Craft A, TOBOTMRCBO06AEORTC80931CAEOI; (2007) Intensified chemotherapy improved histological response but not survival in patients with operable osteosarcoma of an extremity: results of a randomised phase III study of the European Osteosarcoma Intergroup (MRC BO06 80931 ISRCTN86294690). Journal of the National Cancer Institute , 99 112 - 128.

Whelan, JS; Fern, L; (2007) Cancer in adolescence: Incidence and policy issues. In: Kelly, D and Gibson, F, (eds.) Cancer in Adolescents and Young People: Care and Policy Issues. Blackwell: Oxford.

Wilkins, D; Mayer, A; Sharma, S; Tolner, B; Springer, C; Hartley, J; ... Begent, R; + view all (2007) Interim Results of a Phase I/II Trial of Antibody Directed Enzyme Prodrug Therapy (ADEPT) in Patients with Gastrointestinal Carcinoma. In: (Proceedings) NCRI Cancer Conference Proceedings.

Wood, K; Saunders, MI; Honess, DJ; Maxwell, RJ; Wilson, J; Paul, RL; ... Blower, PJ; + view all (2007) Evaluation of the effects of blood flow on 64Cu-ATSM distribution in a rodent tumour model. In: Radiotherapy & Oncology. (pp. S35 - S36).

Wood, KA; Hoskin, PJ; Saunders, MI; (2007) Positron emission tomography in oncology: A review. CLIN ONCOL-UK , 19 (4) 237 - 255. 10.1016/j.clon.2007.02.001.

Wylie, JP; Mandall, P; Bottomley, D; Hoskin, PJ; (2007) Multi-institutional UK prostate brachytherapy database. In: CLINICAL ONCOLOGY. (pp. S50 - S51).

Wynne, P; Newton, C; Ledermann, J; Olaitan, A; Mould, TA; Hartley, JA; (2007) Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy. BRIT J CANCER , 97 (7) 927 - 933. 10.1038/sj.bjc.6603973.

This list was generated on Sun Sep 28 03:45:49 2014 BST.